Reviva Pharmaceuticals Holdings, Inc. (RVPHW)

Market Cap	39.97M
Revenue (ttm)	n/a
Net Income (ttm)	-29.92M
Shares Out	46.74M
EPS (ttm)	-0.90
PE Ratio	n/a
Forward PE	n/a
Dividend	n/a
Ex-Dividend Date	n/a

Volume	n/a
Open	n/a
Previous Close	0.0617
Day's Range	n/a
52-Week Range	0.0430 - 0.0543
Beta	0.05
Analysts	n/a
Price Target	n/a
Earnings Date	Mar 14, 2025

About RVPHW

Reviva Pharmaceuticals Holdings, Inc., a biopharmaceutical company, discovers, develops, and commercializes next-generation therapeutics for diseases targeting unmet medical needs in the areas of central nervous system, respiratory, inflammatory, and cardiometabolic diseases. The company’s lead product candidate comprises brilaroxazine (RP5063) for the treatment of various neuropsychiatric indications, including schizophrenia, bipolar disorder, major depressive disorder, attention–deficit/hyperactivity disorder, behavioral and psychotic symptom...

• Industry: Biotechnology
• Sector: Healthcare
• Founded: 2018
• Employees: 14
• Stock Exchange: NASDAQ
• Ticker Symbol: RVPHW
• Website: https://www.revivapharma.com